TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
GENB

Generate Biomedicines, Inc.

Healthcare · Biotechnology

16.00$ -3.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow GENB
Line item 2024 2025
-0.92 -4.01
0.12 0.26
0.15 0.41
0.22 -0.29
0.03 0.07
-0.45 2.33
-0.09 -0.16
0.72 0.56
-0.66 -1.11
-0.95 -4.08

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?